» Articles » PMID: 958506

Pharmacokinetics of Phenprocoumon in Man Investigated Using a Gas Chromatographic Method of Drug Analysis

Overview
Specialty Pharmacology
Date 1976 May 1
PMID 958506
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

A gas chromatographic method for the determination of phenprocoumon (Marcumar) in serum and urine is described, which facilitates accurate values down to 0.5 mug phenprocoumon/ml serum. After the i.v. administration of 20 mg phenprocoumon in a single dose to 4 healthy volunteers the following pharmacokinetic data were obtained: After the initial fast decrease (phase 1) of the serum level of phenprocoumon, probably due to the distribution into the different compartments is followed by a subsequent slower fall (phase 2) which occurs with a serum half-life of 157 h. The apparent distribution volume was 6.51. Analysis of the urine demonstrated that 90% of the excreted phenprocoumon detected was in the glucuronide form.

Citing Articles

Pharmacogenetics of oral anticoagulants: a basis for dose individualization.

Stehle S, Kirchheiner J, Lazar A, Fuhr U Clin Pharmacokinet. 2008; 47(9):565-94.

PMID: 18698879 DOI: 10.2165/00003088-200847090-00002.


Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.

Ufer M Clin Pharmacokinet. 2005; 44(12):1227-46.

PMID: 16372822 DOI: 10.2165/00003088-200544120-00003.


Lack of effect of cimetidine on action of phenprocoumon.

Harenberg J, Zimmermann R, Staiger C, de Vries J, Walter E, Weber E Eur J Clin Pharmacol. 1982; 23(4):365-7.

PMID: 7173307 DOI: 10.1007/BF00613622.


Cimetidine does not increase the anticoagulant effect of phenprocoumon.

Harenberg J, Staiger C, de Vries J, Walter E, Weber E, Zimmermann R Br J Clin Pharmacol. 1982; 14(2):292-3.

PMID: 7104184 PMC: 1427747. DOI: 10.1111/j.1365-2125.1982.tb01979.x.


The influence of dimethylbiguanide on phenprocoumon elimination and its mode of action. A drug interaction study.

Ohnhaus E, Berger W, DUCKERT F, Oesch F Klin Wochenschr. 1983; 61(17):851-8.

PMID: 6632727 DOI: 10.1007/BF01537460.


References
1.
TRAGER W, Lewis R, Garland W . Mass spectral analysis in the identification of human metabolites of warfarin. J Med Chem. 1970; 13(6):1196-204. DOI: 10.1021/jm00300a041. View

2.
Huthwohl B, Jahnchen E . Displacement of phenprocoumon (Marcumar) from albumin by sulfonylurea compounds, suramin, and ioglycamic acid. Naunyn Schmiedebergs Arch Pharmacol. 1972; 273(3):204-12. DOI: 10.1007/BF00501412. View

3.
Lewis R, TRAGER W . Warfarin metabolism in man: identification of metabolites in urine. J Clin Invest. 1970; 49(5):907-13. PMC: 535763. DOI: 10.1172/JCI106310. View

4.
GLOGNER P, Heni N . [Pharmacokinetica and metabolism of phenprocoumon--"marcumar" in man]. Verh Dtsch Ges Inn Med. 1973; 79:1308-11. View

5.
Seiler K, DUCKERT F . Properties of 3-(1-phenyl-propyl)-4-oxycoumarin (marcoumar) in the plasma when tested in normal cases and under the influence of drugs. Thromb Diath Haemorrh. 1968; 19(3):89-96. View